Trials / Conditions / Stage IIB Non-small Cell Lung Cancer

Stage IIB Non-small Cell Lung Cancer

19 registered clinical trials studyying Stage IIB Non-small Cell Lung Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC NCT05894889	Peking University	Phase 2
Completed	Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consoli NCT03916419	Washington University School of Medicine	Phase 2
Active Not Recruiting	Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery NCT03433469	University of California, San Francisco	Phase 2
Completed	Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuita NCT02262325	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non NCT02243748	City of Hope Medical Center	N/A
Withdrawn	Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer NCT02059889	Virginia Commonwealth University	N/A
Withdrawn	Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC NCT02059967	Virginia Commonwealth University	Phase 1
Completed	Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients NCT01999881	University of Wisconsin, Madison	N/A
Completed	Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect NCT01726296	Fox Chase Cancer Center	N/A
Completed	Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer NCT01741636	City of Hope Medical Center	N/A
Terminated	Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer NCT01707823	Vanderbilt-Ingram Cancer Center	EARLY_Phase 1
Unknown	An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT01711697	Emory University	Phase 1
Completed	Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer NCT01840150	Fox Chase Cancer Center	N/A
Not Yet Recruiting	Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Canc NCT01595074	National Cancer Institute (NCI)	—
Terminated	Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot B NCT01411098	University of Washington	Phase 1
Active Not Recruiting	Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination NCT01345851	Jonsson Comprehensive Cancer Center	N/A
Completed	Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer NCT01457469	Wake Forest University Health Sciences	Phase 1
Terminated	Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection NCT00087269	National Cancer Institute (NCI)	Phase 2
Completed	Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Remov NCT00049543	National Cancer Institute (NCI)	Phase 3